Goldman Sachs initiates Talen Energy coverage with Buy rating
Goldman Sachs analyst Carly Davenport initiated coverage on Talen Energy with a Buy rating and a price target of $499, indicating a positive outlook. The stock closed at $409.81 on Wednesday. Other analyst initiations included ratings for Terreno Realty, Relmada Therapeutics, Immix Biopharma, and Constellation Energy.
*this image is generated using AI for illustrative purposes only.
Goldman Sachs analyst Carly Davenport has initiated coverage on Talen Energy with a Buy rating and a price target of $499. The rating reflects a positive outlook on the company's stock performance, suggesting potential upside from current levels. Talen Energy shares closed at $409.81 on Wednesday.
Analyst Details
Carly Davenport, an analyst at Goldman Sachs, provided the coverage initiation. The price target of $499 indicates the firm's valuation expectation for Talen Energy.
Stock Information
Talen Energy is listed on NASDAQ under the ticker symbol TLN. The Buy rating suggests potential upside from current levels.
Other Analyst Initiations
Several other Wall Street analysts initiated coverage on various stocks on Wednesday:
| Company | Analyst | Rating | Price Target | Close Price |
|---|---|---|---|---|
| Terreno Realty Corp | Raymond James (David Rodgers) | Underperform | - | $63.86 |
| Relmada Therapeutics Inc | HC Wainwright & Co. (Andres Y. Maldonado) | Buy | $12 | $6.60 |
| Immix Biopharma Inc | B of A Securities (Tazeen Ahmad) | Buy | $27 | $9.13 |
| Constellation Energy Corp | Goldman Sachs (Carly Davenport) | Neutral | $305 | $267.17 |
What specific factors drove Goldman Sachs to set such a high price target for Talen Energy?
How might Talen Energy's performance compare to other energy stocks with similar analyst ratings?
What are the potential risks that could prevent Talen Energy from reaching the $499 price target?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
